OLMALINC and breast cancer: In our in vitro study, human BC cells treated with anti-PTHrP mAb not only downregulated genes coding for key enzymes in fatty acid metabolism but also disrupted OLMALINC expression, a human ortholog of mouse GM50337 identified in our RNAseq analyses and functionally validated in vitro using the mouse primary BC cells.